A technician holds a laboratory mouse at the Jackson Laboratory, Jan. 24, 2006, in Bar Harbor, Maine. (AP Photo/Robert F. Bukaty, File)
The phase-out focuses on ending animal testing in regard to researching monoclonal antibody therapies, which are lab-made proteins meant to stimulate the immune system to fight diseases such as cancer, as well as other drugs, according to the press release.
Instead, the FDA will encourage testing on "organoids," which are artificially grown masses of cells, according to the FDA's press release obtained by Fox Digital.
MULTIMILLION-DOLLAR BIDEN-ERA COVID-19 VAX PROJECT HALTED BY TRUMP’S HHS
"The FDA will promote the use of lab-grown human ‘organoids' and organ-on-a-chip systems that mimic human organs – such as liver, heart, and immune organs – to test drug safety. These experiments can reveal toxic effects that could easily go undetected in animals, providing a more direct window into human responses," the press release says.
Doctors in hospital operating room (iStock)
The FDA is slated to also work with fellow federal agencies, such as the National Institutes of Health, the National Toxicology Program and the Department of Veterans Affairs, to "accelerate the validation" of the new testing standards and will hold a public workshop later this year to further discuss the matter.
CLICK HERE TO GET THE FOX NEWS APP
"For patients, it means a more efficient pipeline for novel treatments. It also means an added margin of safety, since human-based test systems may better predict real-world outcomes. For animal welfare, it represents a major step toward ending the use of laboratory animals in drug testing. Thousands of animals, including dogs and primates, could eventually be spared each year as these new methods take root," Makary said.
https://www.foxnews.com/politics/fda-phasing-out-some-animal-testing-win-win-ethics-public-health-commissioner